CUE-302

N/A

Report date: 2025/01/26 17:55:00

Base Information

Drug NameCUE-302
Drug Alias NameCUE-300 series (Cue Biopharma/Merck)MHC class II CUE fusion protein (Cue Biopharma/Merck & Co)MHC class II program (Cue Biopharma/Merck & Co)CUE-302
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCue Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co IncCue Biopharma Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A